#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3056823	B	Ratio of trimethorpin IC50 to compound IC50 for Cryptosporidium parvum recombinant DHFR	Cryptosporidium parvum	4		single protein format	Scientific Literature
2.	ALA3056824	B	Inhibition of Homo sapiens (human) dihydrofolate reductase using dihydrofolate as substrate incubated for 5 min prior to substrate addition by spectrophotometric assay	Homo sapiens	12		single protein format	Scientific Literature
3.	ALA3056825	B	Inhibition of Cryptosporidium parvum recombinant DHFR using dihydrofolate as substrate incubated for 5 min prior to substrate addition by spectrophotometric assay	Cryptosporidium parvum	12		single protein format	Scientific Literature
4.	ALA3056826	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as decrease in interstitial pneumonia at 0.25 mg, po administered 48 hr post-infection measured after 3 days by haematoxylin and eosin staining relative to control	Toxoplasma gondii	11		organism-based format	Scientific Literature
5.	ALA3056827	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as decrease in host lung congestion at 0.25 mg, po administered 48 hr post-infection measured after 3 days by haematoxylin and eosin staining relative to control	Toxoplasma gondii	11		organism-based format	Scientific Literature
6.	ALA3056828	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as megakaryocytes in host spleen at 0.25 mg, po administered 48 hr post-infection measured after 3 days by haematoxylin and eosin staining relative to control	Toxoplasma gondii	11		organism-based format	Scientific Literature
7.	ALA3056829	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as extramedullary hematopoiesis in host spleen at 0.25 mg, po administered 48 hr post-infection measured after 3 days by haematoxylin and eosin staining relative to control	Toxoplasma gondii	11		organism-based format	Scientific Literature
8.	ALA3056830	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as epethelioid granuloma in host spleen at 0.25 mg, po administered 48 hr post-infection measured after 3 days by haematoxylin and eosin staining relative to control	Toxoplasma gondii	11		organism-based format	Scientific Literature
9.	ALA3056831	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as increase in host spleen red pulp at 0.25 mg, po administered 48 hr post-infection measured after 3 days by haematoxylin and eosin staining relative to control	Toxoplasma gondii	11		organism-based format	Scientific Literature
10.	ALA3056832	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as decrease in host spleen white pulp at 0.25 mg, po administered 48 hr post-infection measured after 3 days by haematoxylin and eosin staining relative to control	Toxoplasma gondii	11		organism-based format	Scientific Literature
11.	ALA3056833	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as decrease in host spleen necrosis at 0.25 mg, po administered 48 hr post-infection measured after 3 days by haematoxylin and eosin staining relative to control	Toxoplasma gondii	11		organism-based format	Scientific Literature
12.	ALA3056834	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as clear lymphocytes in host liver focal granuloma at 0.25 mg, po administered 48 hr post-infection measured after 3 days by haematoxylin and eosin staining relative to control	Toxoplasma gondii	11		organism-based format	Scientific Literature
13.	ALA3056835	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as clear mononuclear cells in host liver focal granuloma at 0.25 mg, po administered 48 hr post-infection measured after 3 days by haematoxylin and eosin staining relative to control	Toxoplasma gondii	11		organism-based format	Scientific Literature
14.	ALA3056836	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as decrease in host liver necrosis at 0.25 mg, po administered 48 hr post-infection measured after 3 days by haematoxylin and eosin staining relative to control	Toxoplasma gondii	11		organism-based format	Scientific Literature
15.	ALA3056837	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as multiple deep ridged parasite surface in host peritoneal exudate at 0.25 mg, po administered 48 hr post-infection measured after 3 days by scanning electron microscopic analysis	Toxoplasma gondii	1		organism-based format	Scientific Literature
16.	ALA3058726	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as parasite deformity in host peritoneal exudate at 0.25 mg, po administered 48 hr post-infection measured after 3 days by light microscopic analysis	Toxoplasma gondii	11		organism-based format	Scientific Literature
17.	ALA3058727	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as decreased parasite movement in host peritoneal exudate at 0.25 mg, po administered 48 hr post-infection measured after 3 days by light microscopic analysis	Toxoplasma gondii	11		organism-based format	Scientific Literature
18.	ALA3058728	F	Antiparasitic activity Toxoplasma gondii RH infected Swiss albino mouse assessed as decrease in Toxoplasma antigen in host serum at 0.25 mg, po administered 48 hr post-infection measured after 3 days by Co-A test relative to control	Toxoplasma gondii	11		organism-based format	Scientific Literature
19.	ALA3058729	F	Antiparasitic activity against Toxoplasma gondii RH infected Swiss albino mouse assessed as decrease in tachozyte count in spleen at 0.25 mg, po administered 48 hr post-infection measured after 3 days by Geimsa staining relative to control	Toxoplasma gondii	11		organism-based format	Scientific Literature
20.	ALA3058730	F	Antiparasitic activity against Toxoplasma gondii RH infected Swiss albino mouse assessed as decrease in tachozyte count in liver at 0.25 mg, po administered 48 hr post-infection measured after 3 days by Geimsa staining relative to control	Toxoplasma gondii	11		organism-based format	Scientific Literature